MAPT and tauopathy: In previous reports, the capability of Aβ1‐42 to induce Tau aggregation was studied in mice expressing mutant human Tau, models of tauopathies (Lewis et al., 2001; Oddo et al., 2006; Rhein et al., 2009; Nisbet et al., 2015).